Loading clinical trials...

Not Yet RecruitingNANCT06545643

Sleep-Sensitive Seizure Risk Assessment With Wearable EEGs

Epilepsy, a prevalent neurological disorder, affects 40% of patients with uncontrolled seizures despite medications. Sleep disturbance exacerbates epilepsy, and vice versa, but existing literature suf...

Lead sponsor: Duke University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Birgit Frauscher, MD PD

CONTACT

9196139386 birgit.frauscher@duke.edu

Related studies

RECRUITINGEARLY Phase 1

Localizing Epileptic Networks Using MRI and iEEG

NCT04649008 · Epilepsy, Epilepsy Intractable, and more

RECRUITINGNA

Neural Mechanisms of Spatial Representations Beyond the Self

NCT05406349 · Epilepsy Intractable

Enrolling By Invitation

5-SENSE Score Validation Study

NCT06138808 · Epilepsy Intractable

Active Not RecruitingNA

Memory Retrieval and Encoding Investigated by Neural Stimulation

NCT04286776 · Epilepsy Intractable

Not Yet RecruitingNA

Sleep Disruption Pattern - Epilepsy Monitoring Unit

NCT06581133 · Epilepsy Intractable

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 16, 2025Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhaseNA

Enrollment35

Start dateMay 2026

Last updatedDec 16, 2025

Condition

Epilepsy Intractable

Locations shown

Duke University Health System

Durham, North Carolina

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 16, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions